Cite
HARVARD Citation
Derangère, V. et al. (2022). Combination of CDX2 H-score quantitative analysis with CD3 AI-guided analysis identifies patients with a good prognosis only in stage III colon cancer. European journal of cancer. pp. 221-230. [Online].